SODIUM BUTABARBITAL Drug Patent Profile
When do Sodium Butabarbital patents expire, and when can generic versions of Sodium Butabarbital launch?
Sodium Butabarbital is a drug marketed by Hikma, Ivax Sub Teva Pharms, Lannett, and Marshall Pharma. and is included in eight NDAs.
The generic ingredient in SODIUM BUTABARBITAL is butabarbital sodium. There is one drug master file entry for this compound. Additional details are available on the butabarbital sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM BUTABARBITAL?
- What are the global sales for SODIUM BUTABARBITAL?
- What is Average Wholesale Price for SODIUM BUTABARBITAL?
Summary for SODIUM BUTABARBITAL
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,217 |
| DailyMed Link: | SODIUM BUTABARBITAL at DailyMed |
Recent Clinical Trials for SODIUM BUTABARBITAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
US Patents and Regulatory Information for SODIUM BUTABARBITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 085418-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lannett | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 085881-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Sub Teva Pharms | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 084040-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
